|
|
|
|
Sample Preparation and Post-separation Analysis
Searching in 'SWISS-2DPAGE' for entry matching: P02671 |
SWISS-2DPAGE: P02671
P02671:
Nice View - a user-friendly view of this entry
ID FIBA_HUMAN; STANDARD; 2DG.
AC P02671;
DT 01-AUG-1993, integrated into SWISS-2DPAGE (release 0).
DT 31-MAR-2004, 2D annotation version 1.
DT 09-NOV-2011, general annotation version 17.
DE RecName: Full=Fibrinogen alpha chain; Contains: RecName:
DE Full=Fibrinopeptide A; Contains: RecName: Full=Fibrinogen alpha chain;
DE Flags: Precursor;.
GN Name=FGA;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC Hominidae; Homo.
OX NCBI_TaxID=9606;
MT HEPG2SP_HUMAN, PLASMA_HUMAN.
IM HEPG2SP_HUMAN, PLASMA_HUMAN.
RN [1]
RP MAPPING ON GEL.
RX MEDLINE=78094420; PubMed=271964; [NCBI, Expasy, EBI, Israel, Japan]
RA Anderson N.L., Anderson N.G.;
RT ''''''High resolution two-dimensional electrophoresis of human plasma proteins'';'';'';
RL Proc. Natl. Acad. Sci. U.S.A. 74(1):5421-5425(1977).
RN [2]
RP MAPPING ON GEL.
RX MEDLINE=96007934; PubMed=7498157; [NCBI, Expasy, EBI, Israel, Japan]
RA Sanchez J.-C., Appel R.D., Golaz O.G., Pasquali C., Ravier F., Bairoch
RA A., Hochstrasser D.F.;
RT ''''''Inside SWISS-2DPAGE database'';'';'';
RL Electrophoresis 16(1):1131-1151(1995).
CC -!- SUBUNIT: ALPHA, BETA AND GAMMA CHAIN
2D -!- MASTER: HEPG2SP_HUMAN;
2D -!- PI/MW: SPOT 2D-0008SJ=6.71/69531;
2D -!- PI/MW: SPOT 2D-0008SN=6.89/69017;
2D -!- PI/MW: SPOT 2D-0008SP=6.80/69531;
2D -!- PI/MW: SPOT 2D-0008T2=6.98/68001;
2D -!- PI/MW: SPOT 2D-0008TQ=7.13/67249;
2D -!- PI/MW: SPOT 2D-0008TR=7.21/67000;
2D -!- PI/MW: SPOT 2D-0008TX=7.06/67000;
2D -!- PI/MW: SPOT 2D-0008U5=6.79/65912;
2D -!- PI/MW: SPOT 2D-0008UB=6.69/66345;
2D -!- PI/MW: SPOT 2D-0008UF=6.88/65054;
2D -!- PI/MW: SPOT 2D-0008UG=6.97/64842;
2D -!- PI/MW: SPOT 2D-0008UL=7.06/64418;
2D -!- PI/MW: SPOT 2D-0008UP=7.24/63998;
2D -!- MAPPING: MATCHING WITH THE PLASMA MASTER GEL [2].
2D -!- MASTER: PLASMA_HUMAN;
2D -!- PI/MW: SPOT 2D-0004LH=7.65/66818;
2D -!- PI/MW: SPOT 2D-0004LO=6.74/67513;
2D -!- PI/MW: SPOT 2D-0004LP=6.95/67256;
2D -!- PI/MW: SPOT 2D-0004LQ=7.03/67000;
2D -!- PI/MW: SPOT 2D-0004LU=6.85/67256;
2D -!- PI/MW: SPOT 2D-0004LV=7.18/66456;
2D -!- PI/MW: SPOT 2D-0004M2=6.66/66097;
2D -!- PI/MW: SPOT 2D-0004M3=7.39/66456;
2D -!- PI/MW: SPOT 2D-0004M4=6.75/65917;
2D -!- PI/MW: SPOT 2D-0004M5=6.85/65739;
2D -!- PI/MW: SPOT 2D-0004M6=6.94/65739;
2D -!- PI/MW: SPOT 2D-0004MB=7.03/65383;
2D -!- PI/MW: SPOT 2D-0004N4=7.66/64326;
2D -!- PI/MW: SPOT 2D-0004N6=6.65/63459;
2D -!- PI/MW: SPOT 2D-0004N8=7.39/63804;
2D -!- PI/MW: SPOT 2D-0004NE=6.78/63459;
2D -!- PI/MW: SPOT 2D-0004NF=6.89/63287;
2D -!- PI/MW: SPOT 2D-0004NJ=7.00/63115;
2D -!- PI/MW: SPOT 2D-0004NQ=7.18/63115;
2D -!- NORMAL LEVEL: 2000-4500 MG/L.
2D -!- PATHOLOGICAL LEVEL: DECREASED DURING DISSAMINATED INTRAVASCULAR
2D COAGULATION AND HYPERFIBRINOLYSIS; INCREASED DURING ACUTE INFLAMMATION.
2D -!- POSITIONAL VARIANTS: LILLE-1, ROUEN-1, MUNICH-1, DETROIT-1 AND
2D AARHUS-1 VARIANTS.
2D -!- MAPPING: IMMUNOBLOTTING [1].
CC ---------------------------------------------------------------------------
CC This SWISS-2DPAGE entry is copyright the Swiss Institute of Bioinformatics.
CC There are no restrictions on its use by non-profit institutions as long as
CC its content is in no way modified and this statement is not removed.
CC Usage by and for commercial entities requires a license agreement (See
CC http://world-2dpage.expasy.org/swiss-2dpage/docs/license.html or send email from legal@sib.swiss).
CC ---------------------------------------------------------------------------
DR OGP-WWW; P02671.
DR Siena-2DPAGE; P02671; FIBA_HUMAN.
DR UniProtKB/Swiss-Prot; P02671; FIBA_HUMAN.
//
The following 2-D maps are available for this protein:
|
HepG2 Secreted Proteins
|
Plasma
|
---|
SWISS-2DPAGE (search AC)
|